Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study
Open Journal of Blood Diseases · 2012
DOI: 10.4236/ojbd.2012.23012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Blood Diseases, 2012. Verfasst von Massimo Martino und 5 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Martino, M., Callea, I., Moscato, T., Pontari, A., Spiniello, E., & Fedele, R. (2012). Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study. Open Journal of Blood Diseases. https://doi.org/10.4236/ojbd.2012.23012
Vancouver
Martino M, Callea I, Moscato T, Pontari A, Spiniello E, Fedele R. Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study. Open Journal of Blood Diseases. 2012. doi:10.4236/ojbd.2012.23012
BibTeX
@article{Martino2012,
author = {Martino, Massimo and Callea, Ida and Moscato, Tiziana and Pontari, Antonella and Spiniello, Elisa and Fedele, Roberta},
title = {Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study},
journal = {Open Journal of Blood Diseases},
year = {2012},
doi = {10.4236/ojbd.2012.23012}
}
EUVIMED